Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation

Elaine M. Hylek, Darae Ko, Christina L. Cove

Research output: Contribution to journalReview articlepeer-review

40 Scopus citations

Abstract

Worldwide there is a tremendous need for affordable anticoagulants that do not require monitoring. The advent of the non-warfarin oral anticoagulant drugs represents a major advance for stroke prevention in atrial fibrillation (AF). The objectives of this review are to 1) identify gaps in our current knowledge regarding use of these single target anticoagulant drugs; 2) outline the potential implications of these gaps for clinical practice, and thereby, 3) highlight areas of research to further optimise their use for stroke prevention in AF.

Original languageEnglish (US)
Pages (from-to)783-788
Number of pages6
JournalThrombosis and Haemostasis
Volume111
Issue number5
DOIs
StatePublished - 2014

Fingerprint Dive into the research topics of 'Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation'. Together they form a unique fingerprint.

Cite this